NOX isoforms and reactive oxygen species in vascular health

Molecular Interventions

Volumn 11, Issue 1, 2011, Pages 27-35

  Touyz, Rhian M ^a   Briones, Ana M ^a   Sedeek, Mona ^a   Burger, Dylan ^a   Montezano, Augosto C ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; UNCLASSIFIED DRUG;

ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD VESSELS; HEALTH; HUMANS; ISOENZYMES; NADPH OXIDASE; REACTIVE OXYGEN SPECIES;

EID: 79953172586     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.11.1.5     Document Type: Review

References (96)

1. Sedeek M, Hébert RL, Kennedy CR, Burns KD, and Touyz RM (2009) Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens 18:122-127.
2. Fridovich I (1997) Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J Biol Chem 272:18515-18517.
3. Koenitzer JR and Freeman BA (2010) Redox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular disease. Ann N Y Acad Sci 1203:45-52.
4. Touyz RM (2005) Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 7:1302-1314.
5. Faraci FM and Didion SP (2004) Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24:1367-1373. (Pubitemid 39050427)
6. Mendez JI, Nicholson WJ, and Taylor WR (2005) SOD isoforms and signaling in blood vessels: evidence for the importance of ROS compartmentalization. Arterioscler Thromb Vasc Biol 25:887-888. (Pubitemid 40627829)
7. Welch WJ, Chabrashvili T, Solis G, Chen Y, Gill PS, Aslam S, Wang X, Ji H, Sandberg K, Jose P, and Wilcox CS (2006) Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension 48:934-941. (Pubitemid 44611008)
8. Harrison DG, Widder J, Grumbach I, Chen W, Weber M, and Searles C (2006) Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med 259:351-363. (Pubitemid 43384226)
9. Fortuño A, Bidegain J, Baltanás A, Moreno MU, Montero L, Landecho MF, Beloqui O, Díez J, and Zalba G (2010) Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications. J Hypertens 28:1944-1950.
10. Landmesser U, Harrison DG, and Drexler H (2006) Oxidant stress-a major cause of reduced endothelial nitric oxide availability in cardiovascular disease. Eur J Clin Pharmacol 62:13-19.
11. Virdis A, Neves MF, Amiri F, Touyz RM, and Schiffrin EL (2004) Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22:535-542. (Pubitemid 38368487)
12. Nistala R, Wei Y, Sowers JR, and Whaley-Connell A (2009) Reninangiotensin- aldosterone system-mediated redox effects in chronic kidney disease. Transl Res 153:102-13.
13. Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181-189.
14. Babior BM (2004) NAD(P)H oxidase. Curr Opin Immunol 16:42-47.
15. Vignais PV (2002) The superoxide-generating NAD(P)H oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59:1428-1459.
16. Taura M, Miyano K, Minakami R, Kamakura S, Takeya R, and Sumimoto H (2009) A region N-terminal to the tandem SH3 domain of p47phox plays a crucial role in the activation of the phagocyte NAD(P)H oxidase. Biochem J 419:329-338.
17. Lopes LR, Dagher MC, Gutierrez A, Young B, Bouin AP, Fuchs A, and Babior BM (2004) Phosphorylated p40PHOX as a negative regulator of NADPH oxidase. Biochemistry 43:3723-3730. (Pubitemid 38391727)
18. Bokoch GM and Zhao T (2006) Regulation of the phagocyte NAD(P)H oxidase by Rac GTPase. Antioxid Redox Signal 8:1533-1548. (Pubitemid 44726329)
19. Leto TL, Morand S, Hurt D, and Ueyama T (2009) Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 11:260.
20. Petry A, Weitnauer M, and Görlach A (2010) Receptor activation of NADPH oxidases. Antioxid Redox Signal 13:467.
21. Nisimoto Y, Tsubouchi R, Diebold BA, Qiao S, Ogawa H, Ohara T, and Tamura M (2008) Activation of NAD(P)H oxidase 1 in tumour colon epithelial cells. Biochem J 415:57-65.
22. Muzaffar S, Shukla N, Bond M, Newby AC, Angelini GD, Sparatore A, Del Soldato P, and Jeremy JY (2008) Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res 45:521-528.
23. Dutta S and Rittinger K (2010) Regulation of NOXO1 activity through reversible interactions with p22 and NOXA1. PLoS One 5:e10478.
24. Honjo T, Otsui K, Shiraki R, Kawashima S, Sawamura T, Yokoyama M, and Inoue N (2008) Essential role of NOXA1 in generation of reactive oxygen activation of species induced by oxidized low-density lipoprotein in human vascular endothelial cells. Endothelium 15:137-141. (Pubitemid 351891378)
25. Gianni D, Dermardirossian C, and Bokoch GM (2011) Direct interaction between Tks proteins and the N-terminal proline-rich region (PRR) of NoxA1 mediates Nox1-dependent ROS generation. Eur J Cell Biol 90:164-171.
26. Diaz B, Shani G, Pass I, Anderson D, Quintavalle M, and Courtneidge SA (2009) Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci Signal 2:ra53.
27. Kroviarski Y, Debbabi M, Bachoual R, Périanin A, Gougerot-Pocidalo MA, El-Benna J, and Dang PM (2010) Phosphorylation of NADPH oxidase activator 1 (NOXA1) on serine 282 by MAP kinases and on serine 172 by protein kinase C and protein kinase A prevents NOX1 hyperactivation. FASEB J 24:2077-2092.
28. Fernandes DC, Manoel AHO, Wosniak J, and Laurindo FR (2009) Protein disulfide isomerise overexpression in vascular smooth muscle cells induces spontaneous preemptive NAD(P)H oxidase activation nad Nox1 mRNA expression: effects of nitrosothiol exposure. Arch Biochem Biophys 484:197-204.
29. Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, Lyons E, Krause KH, Banfi B, Lambeth JD, et al. (2009) Mechanisms of vascular smooth muscle NAD(P)H oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 29:480-487.
30. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation (2003) Am J Physiol Regul Integr Comp Physiol 285:R277-297.
31. Manea A, Tanase LI, Raicu M, and Simionescu M (2010) Transcriptional regulation of NADPH oxidase isoforms Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophys Res Commun 396:901-907.
32. Wei H, Mi X, Ji L, Yang L, Xia Q, Wei Y, Miyamori I, and Fan C (2010) Protein kinase C-delta is involved in induction of NOX1 gene expression by aldosterone in rat vascular smooth muscle cells. Biochemistry 75:304-309.
33. Stanic B, Katsuyama M, and Miller FJ Jr (2010) An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation. Arterioscler Thromb Vasc Biol 30:2234-2241.
34. Tabet F, Schiffrin EL, Callera GE, He Y, Yao G, Ostman A, Kappert K, Tonks NK, and Touyz RM (2008) Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR. Circ Res 103:149-154.
35. Wosniak J Jr, Santos CX, Kowaltowski AJ, and Laurindo FR (2009) Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells. Antioxid Redox Signal 11:1265-1278.
36. Rivera J, Sobey CG, Walduck AK, and Drummond GR (2010) Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep 15:50-63.
37. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK (2002) Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91:406-413. (Pubitemid 35034208)
38. Dikalova AE, Góngora MC, Harrison DG, Lambeth JD, Dikalov S, and Griendling KK (2010) Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol 299:H673-H679.
39. Yogi A, Mercure C, Touyz J, Callera GE, Montezano AC, Aranha AB, Tostes RC, Reudelhuber T, and Touyz RM (2008) Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension 51:500-506. (Pubitemid 351156439)
40. Niu XL, Madamanchi NR, Vendrov AE, Tchivilev I, Rojas M, Madamanchi C, Brandes RP, Krause KH, Humphries J, Smith A, et al. (2010) Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation 121:549-59.
41. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, and Schiffrin EL (2002) Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90:1205-1213. (Pubitemid 34786906)
42. Wind S, Beuerlein K, Armitage ME, Taye A, Kumar AH, Janowitz D, Neff C, Shah AM, Wingler K, and Schmidt HH (2010) Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 56:490-497.
43. Kim SY, Lee JG, Cho WS, Cho KH, Sakong J, Kim JR, Chin BR, and Baek SH (2010) Role of NADPH oxidase-2 in lipopolysaccharide-induced matrix metalloproteinase expression and cell migration. Immunol Cell Biol 88:197-204.
44. Lassègue B and Griendling KK (2010) NADPH oxidases: functions and pa and sure thologies in the vasculature. Arterioscler Thromb Vasc Biol 30:653-661.
45. Han W, Li H, Villar VA, Pascua AM, Dajani MI, Wang X, Natarajan A, Quinn MT, Felder RA, Jose PA, et al. (2008) Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension 51:481.
46. Gupte SA, Kaminski PM, George S, Kouznestova L, Olson SC, Mathew R, Hintze TH, and Wolin MS (2009) Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction. Am J Physiol Heart Circ Physiol 296:H1048-1057.
47. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, and Wilcox CS (2002) Expression and cellular localization of classic NAD(P)H oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269-274. (Pubitemid 34165227)
48. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, and Görlach A (2006) NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 8:1473-1484. (Pubitemid 44726324)
49. Touyz RM, Mercure C, He Y, Javeshghani D, Yao G, Callera GE, Yogi A, Lochard N, and Reudelhuber TL (2005) Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phoxcontaining NAD(P)H oxidase. Hypertension 45:530-537. (Pubitemid 40411255)
50. Chen H, Song YS, and Chan PH (2009) Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J Cereb Blood Flow Metab 29:1262-1272.
51. Violi F, Sanguigni V, Carnevale R, Plebani A, Rossi P, Finocchi A, Pignata C, De Mattia D, Martire B, Pietrogrande MC, et al. (2009) Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation 120:1616-1622.
52. Loukogeorgakis SP, van den Berg MJ, Sofat R, Nitsch D, Charakida M, Haiyee B, de Groot E, MacAllister RJ, Kuijpers TW, and Deanfield JE (2010) Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans. Circulation 121:2310-2316.
53. Montezano AC, Burger D, Ceravolo GS, Yusuf H, Montero M, and Touyz RM (2010) Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5. Clin Sci (Lond) 120:131-141.
54. Geiszt M, Kopp JB, Várnai P, and Leto TL (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97:8010-8014. (Pubitemid 30460764)
55. Nabeebaccus A, Zhang M, and Shah AM (2011) NADPH oxidases and cardiac remodelling. Heart Fail Rev 16:5-12.
56. Sedeek M, Callera GE, Montezano A, Gutsol A, Heitz F, Szyndralewiez C, Page P, Kennedy CR, Burns KD, Touyz RM, et al. (2010) Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol 299:1348-1358.
57. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK (2004) Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24:677-683. (Pubitemid 38451603)
58. Kuroda J, Nakagawa K, Yamasaki T, Nakamura K, Takeya R, Kuribayashi F, Imajoh-Ohmi S, Igarashi K, Shibata Y, Sueishi K, et al. (2005) The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10:1139-1151. (Pubitemid 41830073)
59. Chen K, Kirber MT, Xiao H, Yang Y, and Keaney JF Jr (2008) Regulation of ROS signal transduction by NAD(P)H oxidase 4 localization. J Cell Biol 181:1129-1139. (Pubitemid 351915488)
60. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassègue B, and Griendling KK (2009) Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105:249-259.
61. Wu RF, Ma Z, Liu Z, and Terada LS (2010) Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local Ras activation. Mol Cell Biol 30:3553-3568.
62. Schröder K (2010) Isoform specific functions of Nox protein-derived reactive oxygen species in the vasculature. Curr Opin Pharmacol 10:122-126.
63. Manea A, Tanase LI, Raicu M, and Simionescu M (2010) Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 30:105-112.
64. Ismail, A. Sturrock, P. Wu, B. Cahill, K. Norman, T. Huecksteadt, K. Sanders, T. Kennedy, and Hoidal J (2009) NOX4 mediates hypoxiainduced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. Am J Physiol lung Cell Mol Physiol 296:489-499.
65. Pendyala S and Natarajan V (2010) Redox regulation of Nox proteins. Respir Physiol Neurobiol 174:265-271.
66. Lener B, Kozieł R, Pircher H, Hütter E, Greussing R, Herndler- Brandstetter D, Hermann M, Unterluggauer H, and Jansen-Dürr P (2009) The NADPH oxidase Nox4 restricts the replicative lifespan of human endothelial cells. Biochem J 423:363-374.
67. Schilder YD, Heiss EH, Schachner D, Ziegler J, Reznicek G, Sorescu D, and Dirsch VM (2009) NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radic Biol Med 46:1598-606.
68. Wang M, Zhang J, Walker SJ, Dworakowski R, Lakatta EG, and Shah AM (2010) Involvement of NADPH oxidase in age-associated cardiac remodeling. J Mol Cell Cardiol 48:765-772
69. Schröder K, Wandzioch K, Helmcke I, and Brandes RP (2009) Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler Thromb Vasc Biol 29:239-245.
70. Zhang M, Brewer AC, Schröder K, Santos CX, Grieve DJ, Wang M, Anilkumar N, Yu B, Dong X, Walker SJ, et al. (2010) NADPH oxidase- 4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A 107:18121-18126.
71. Serrander L, Jaquet V, Bedard K, Plastre O, Hartley O, Arnaudeau S, Demaurex N, Schlegel W, and Krause KH (2007) NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation. Biochimie 89:1159-1167. (Pubitemid 47248008)
72. Jagnandan D, Church JE, Banfi B, Stuehr DJ, Marrero MB, and Fulton DJ (2007) Novel mechanism of activation of NAD(P)H oxidase 5. calcium sensitization via phosphorylation. J Biol Chem 282:6494-6507. (Pubitemid 47100887)
73. Fulton DJ (2009) Nox5 and the regulation of cellular function. Antioxid Redox Signal 11:2443-2452.
74. Schulz E and Münzel T (2008) NOX5, a new "radical" player in human atherosclerosis? J Am Coll Cardiol 52:1810-1812.
75. Jay DB, Papaharalambus CA, Seidel-Rogol B, Dikalova AE, Lassègue B, and Griendling KK (2008) Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radic Biol Med 45:329-335.
76. Montezano AC, Paravicini TM, Chignalia AZ, Yusuf H, Almasri M, He Y, He G, Callera GE, Krause K-H, Lambeth D, et al. (2010) Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent pathways in human endothelial cells. Circ Res 106:1363-1373.
77. Fu X, Beer DG, Behar J, Wands J, Lambeth D, and Cao W (2006) cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 281:20368-20382. (Pubitemid 44065811)
78. Haurani MJ, Cifuentes ME, Shepard AD, and Pagano PJ (2008) Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration. Hypertension 52:143-149.
79. Touyz RM and Briones A (2011) Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens Res 34:5-14.
80. Selemidis S, Sobey CG, Wingler K, Schmidt HH, and Drummond GR (2008) NAD(P)H oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120:254-291.
81. Li S, Tabar SS, Malec V, Eul BG, Klepetko W, Weissmann N, Grimminger F, Seeger W, Rose F, and Hänze J (2008) NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Antioxid Redox Signal 10:1687-1698.
82. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK (2004) Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24:677-683. (Pubitemid 38451603)
83. Schröder K, Wandzioch K, Helmcke I, and Brandes RP (2009) Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler Thromb Vasc Biol 29:239-245.
84. Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM, and Lee RM (2006) Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res 71:363-373.
85. BelAiba RS, Djordjevic T, Petry A, Diemer K, Bonello S, Banfi B, Hess J, Pogrebniak A, Bickel C, and Görlach A (2007) NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med 42:446-459. (Pubitemid 46162114)
86. Takeya R and Sumimoto H (2006) Regulation of novel superoxide-producing NAD(P)H oxidases. Antioxid Redox Signal 8:1523-1532. (Pubitemid 44726328)
87. Ambasta RK, Schreiber JG, Janiszewski M, Busse R, and Brandes RP (2006) Noxa1 is a central component of the smooth muscle NAD(P)H oxidase in mice. Free Radic Biol Med 41:193-201. (Pubitemid 43928491)
88. Cheng G and Lambeth JD (2005) Alternative mRNA splice forms of NOXO1: differential tissue expression and regulation of Nox1 and Nox3. Gene 356:118-126. (Pubitemid 41175977)
89. Ibi M, Matsuno K, Shiba D, Katsuyama M, Iwata K, Kakehi T, Nakagawa T, Sango K, Shirai Y, Yokoyama T, et al. (2008) Reactive oxygen species derived from NOX1/NAD(P)H oxidase enhance inflammatory pain. J Neurosci 28:9486-9494.
90. Peng YJ, Yuan G, Jacono FJ, Kumar GK, and Prabhakar NR (2006) 5-HT evokes sensory long-term facilitation of rodent carotid body via activation of NAD(P)H oxidase. J Physiol 576:289-295. (Pubitemid 44426237)
91. Brandes RP and Schröder K (2008) Differential vascular functions of Nox family NAD(P)H oxidases. Curr Opin Lipidol 19:513-518.
92. Diebold I, Petry A, Hess J, and Görlach A (2010) The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor 1. Mol Biol Cell 21:2087.
93. Bohl B, Courtneidge SA, and Bokoch GM (2008) The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase 1. Mol Biol Cell 19:2984-2994.
94. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, and Braut- Boucher F (2009) p47phox, the phagocyte NAD(P)H oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med 41:217-225.
95. Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL, and Touyz RM (2008) Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Srcregulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol 28:1511-1518.
96. Block K, Eid A, Griendling KK, Lee DY, Wittrant Y, and Gorin Y (2008) Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem 283:24061-24076.